ATAD1 and malaria: To evaluate the frequency of antibody responses to PvRMC-MSP1 in a naturally exposed population, plasma samples collected from 258 individuals living in two areas where P. vivax accounts for more than 70% of the clinical cases of malaria were assessed by ELISA.